Stock Events

Stock Events

BioPharma Credit 

0
165
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jul 26
€0.02
May 26
€0.01
Mar 26
€0.01
Mar 26
€0.01
Oct 25
€0.01
10Y Growth
N/A
5Y Growth
-0.29%
3Y Growth
-2.8%
1Y Growth
-4.29%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BPCR.MU. It's not an investment recommendation.
Legal & General Group
34
LGEN.LSE
Greencoat UK Wind
26
UKW.LSE
Aviva
23
AV.LSE
The Renewables Infrastructure Group Limited
22
TRIG.LSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
BridgeBio Pharma
BBIO
Mkt Cap14.63B
BridgeBio Pharma focuses on genetic diseases and competes in the biopharma financing space by attracting investments for its projects.
Pfizer
PFE
Mkt Cap162.16B
Pfizer is a large pharmaceutical company with a significant investment arm for biopharma ventures, competing for similar investment opportunities.
Gilead Sciences
GILD
Mkt Cap187.23B
Gilead Sciences invests in biopharma companies and projects, directly competing with BioPharma Credit's investment model.
Bristol-Myers Squibb
BMY
Mkt Cap136.49B
Bristol Myers Squibb, through its venture arm, competes in the biopharma credit and investment space.
Merck
MRK
Mkt Cap370.89B
Merck & Co., with its venture capital initiatives, competes for similar biopharma investments and financing opportunities.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson, through its J&J Innovation and JLABS units, competes in the biopharma investment and financing space.
Abbvie
ABBV
Mkt Cap453.19B
AbbVie, with its venture investment arm, competes for opportunities in biopharma credit and financing.
AMGEN
AMGN
Mkt Cap236.38B
Amgen, through its venture investments, competes in the biopharma financing space, targeting similar companies and projects.
Novartis
NVS
Mkt Cap304.1B
Novartis, with its significant investments in biopharma companies, competes directly with BioPharma Credit's financing model.
Sanofi
SNY
Mkt Cap106.01B
Sanofi, through its venture capital arm, competes in the biopharma credit market, financing similar types of companies and projects.

About

Operating as an investment trust, BioPharma Credit PLC primarily allocates its capital to debt instruments that generate interest. The security for these investments is provided by royalties or other cash streams originating from the commercial sale of approved life sciences products. This company was established in 2016 and its headquarters are situated in Exeter, United Kingdom.
Show more...
CEO
Pedro Gonzalez de Cosio
Employees
15
Country
United Kingdom
ISIN
GB00BDGKMY29
WKN
000A2DN3S

Listings

OTC Link
US
BOPCF
STU
DE
B3P.STU
MU
DE
BPCR.MU
LSE
GB
BPCP.LSE

0 Comments

Share your thoughts

FAQ

What is BioPharma Credit stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange BioPharma Credit stocks are traded under the ticker BPCR.MU.
Does BioPharma Credit pay dividends?▼
Yes, BPCR.MU dividends are paid quarterly. The last dividend per share was 0.02 EUR. As of today, Dividend Yield (FWD)% is 0%.
How many employees does BioPharma Credit have?▼
As of September 09, 2026, the company has 15 employees.
In which sector is BioPharma Credit located?▼
BioPharma Credit operates in the Finance & Payments sector.
When did BioPharma Credit complete a stock split?▼
BioPharma Credit has not had any recent stock splits.
Where is BioPharma Credit headquartered?▼
BioPharma Credit is headquartered in London, United Kingdom.